Care starts with symptom history, photographs, medication review, physical findings, and focused testing when indicated. Treatment usually begins with non-sedating H1 antihistamines before a specialist considers a biologic for persistent symptoms.
Call 911 for tongue or throat swelling, breathing difficulty, fainting, rapidly worsening symptoms, or suspected anaphylaxis. A chronic-hives appointment is not emergency treatment.
Hives that recur for more than six weeks are chronic. Chronic spontaneous urticaria means the wheals or swelling occur without a consistent external trigger. It can disrupt sleep, work and daily life even when no food or environmental allergy explains it. Confirming the type of hives helps avoid unnecessary testing and unsuitable treatment.
Histamine and immune signaling contribute to itching and swelling. H1 antihistamines are usually part of initial care. If symptoms persist, options include Xolair, which targets IgE; Dupixent, which blocks IL-4/IL-13 signaling; and the oral BTK inhibitor Rhapsido. Their US age limits, routes, doses and safety needs differ, so they are not interchangeable plans.
A clinician reviews the pattern and duration, photographs, swelling, medicines and physical triggers. Xolair’s CSU indication starts at age 12; Dupixent’s starts at age 2; Rhapsido is for adults. Each is indicated for CSU remaining symptomatic despite H1 antihistamines. These approvals do not extend to every form of hives.
Begin with diagnosis and review of prior antihistamine use and response. Testing is guided by the history rather than automatically ordering a large allergy panel. If advanced treatment is considered, select the medicine, review safety and arrange coverage and follow-up. Discuss how itching, hives, swelling and sleep will be recorded before starting.
Bring dated photos, a symptom diary, all medicines and supplements, prior test results and the names and doses of treatments tried. Tell the clinician about pregnancy, infections, bleeding, planned surgery and previous serious reactions. A record of persistent symptoms and appropriate prior treatment may support authorization, but it cannot guarantee approval.
Throat swelling, trouble breathing, fainting or rapidly progressing symptoms need emergency care rather than a routine hives appointment. Xolair can cause anaphylaxis. Rhapsido has bleeding and drug-interaction precautions, including a prescriber-directed pause around surgery. Dupixent has product-specific eye, infection and vaccination precautions. Report new or troublesome symptoms promptly.
Use a consistent symptom measure: days with hives, itch intensity, swelling, rescue medicines and sleep disruption. Review response and adverse effects with the prescriber. Response varies; another person’s rapid improvement is not a prediction. Do not combine advanced medicines, change injection doses or stop antihistamines without the treating clinician’s plan.
Confirm whether the clinic evaluates CSU, coordinates a specialist, prescribes the chosen treatment or administers injections. An oral prescription and an injection visit use different access routes. Manufacturer support does not establish insurer approval or free treatment. Ask about refills, pharmacy shipment, monitoring and costs before relying on a sample or a first dose.
Nao Medical Astoria: 37-15 23rd Ave, Astoria, NY 11105. Call +1-917-310-3371 to confirm the specific service, clinician and appointment before travelling.
Contact the clinic to confirm this service, the clinician and appointment preparation. General clinic hours may differ from service appointment times.
The Astoria clinic is at 37-15 23rd Ave, Astoria, NY 11105. Call the selected clinic to confirm today’s hours, the exact service and the appointment. An address does not prove onsite medication, testing or procedure availability.
A consultation starts with the clinical review and required records. Treatment or a procedure depends on suitability, the actual order, safety checks, staff, supplies and any authorization; booking does not guarantee a dose or procedure that day. Begin with diagnosis and review of prior antihistamine use and response. Testing is guided by the history rather than automatically ordering a large allergy panel. If advanced treatment is considered, select the medicine, review safety and arrange coverage and follow-up. Discuss how itching, hives, swelling and sleep will be recorded before starting.
Bring dated photos, a symptom diary, all medicines and supplements, prior test results and the names and doses of treatments tried. Tell the clinician about pregnancy, infections, bleeding, planned surgery and previous serious reactions. A record of persistent symptoms and appropriate prior treatment may support authorization, but it cannot guarantee approval.
The Rhapsido label does not require a universal scheduled blood-test program. It does require review of bleeding, liver disease, interacting medicines and surgery. The clinician may order tests for your history, symptoms or another medicine; “no routine monitoring” is not a promise that no tests are ever needed.
Rhapsido is remibrutinib, an oral small-molecule BTK inhibitor for adults with CSU that remains symptomatic despite H1 antihistamines. It is neither a shot nor a topical treatment, and it is not an oral biologic. The label uses 25 mg twice daily; bleeding, liver disease and drug interactions need review.
No. Rhapsido is labeled for adults with confirmed chronic spontaneous urticaria that remains symptomatic despite H1 antihistamine treatment. It is not approved for every cause of hives. The clinician should assess the duration and pattern, other diagnoses, prior treatment and safety before prescribing.
Rhapsido increases bleeding risk. Report unusual bruising or bleeding and tell the prescriber about planned surgery and medicines that affect bleeding. The label calls for considering interruption 3 to 7 days before and after surgery according to the procedure and risk. The prescriber should set that plan; severe bleeding needs urgent care.
No. A manufacturer support service may help explain access or savings options, but the insurer makes its own coverage decision. Eligibility, exclusions and program terms apply. Confirm authorization, your pharmacy or administration benefit and the cost of ongoing refills; support enrollment or a sample is not coverage approval.
Review Nao Medical's urgent and emergency care guidance. Call 911 for a life-threatening emergency.
Bronx
932 E 174th St, Bronx, NY 10460
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Queens
37-15 23rd Ave, Astoria, NY 11105
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Bronx
2063A Bartow Ave, Bronx, NY 10475
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Queens
30-07 36th Ave, Astoria, NY 11106
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Long Island
135 Mineola Blvd, Mineola, NY 11501
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Manhattan
259 1st Ave, New York, NY 10003
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Call to arrange an evaluation for chronic hives and urticaria care. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Eligibility, access, administration, and follow-up for Xolair in eligible CSU after H1 antihistamine treatment.
Eligibility, access, administration, and follow-up for Dupixent in eligible CSU after H1 antihistamine treatment.
General Xolair access, administration, observation, and outside-order questions.
General Dupixent training, access, delivery, and follow-up questions.
Transfer support, specialty-pharmacy delivery, confirmed site planning, and product-specific safety.
A separate pathway for reproducible reactions linked to a specific food exposure.
Medication reconciliation and coordination for other health conditions that affect the treatment plan.
CSU definition, limited diagnostic workup, antihistamine-first treatment pathway, symptom tracking, and escalation principles.
Approved indications, age boundaries, dose inputs, boxed anaphylaxis warning, administration, limitations of use, and patient counseling.
April 2026 CSU indication, asthma indication, administration and training, limitations of use, warnings, and patient counseling.
Updated August 1, 2026. This information does not replace an individual medical evaluation. A licensed clinician determines diagnosis, medication eligibility, testing, dosing, administration, and follow-up. Contact Nao Medical with a medical-content question or correction.
(917) 310-3371